Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02060630 · ClinicalTrials.gov registry record · NA
Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia
A NA study, sponsored by Carelon Research.
- Completed
- Registry status
- NA
- Development phase
- 1,843
- Enrollment target
NCT02060630: Completed NA study, sponsored by Carelon Research.
NCT02060630 is a NA study that has completed, run by Carelon Research. The registered enrollment target is 1,843 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02060630, a NA study, has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,843 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia (CLI) who are eligible for both treatment options.
Primary Outcome
* Time to major adverse limb event or death, whichever occurs first in subjects with Single-Segment Great Saphenous Vein (SSGSV) available * Time to major adverse limb event or death, whichever occurs first in subjects without available SSGSV
Interventions
- PROCEDURE Open surgical revascularization
- DEVICE Endovascular revascularization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,843 participants |
| Start Date | 2014-08 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
What the finished NCT02060630 record still lists
NCT02060630 is an interventional study that assigns participants to a tested intervention. Its 1,843 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% higher).
The record links to 0 conditions, and to 2 interventions - of which Open surgical revascularization is the first listed.
NCT02060630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02060630 about?
NCT02060630 is a clinical study titled "Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia". This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia (CLI) who are eligible for both treatment options.
What is the current status of trial NCT02060630?
This trial is currently completed. It is a NA study. The enrollment target is 1,843 participants. The study started on 2014-08. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT02060630?
The interventions under investigation include: Open surgical revascularization (PROCEDURE), Endovascular revascularization (DEVICE).
Who is sponsoring clinical trial NCT02060630?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02060630's enrollment target sits among peer trials
1,843 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia